ASLAN Pharmaceuticals’ $42 Million Initial Public Offering

Michael Patrini Asia & Pacific, Asia & Pacific Legal Chronicle

Cooley advised ASLAN Pharmaceuticals Limited on its $42 million initial public offering of 6,000,000 American Depositary Shares, each representing five ordinary shares. Leerink Partners and Piper…

Membership Required

You must be a member to access this content.

View Membership Levels

Already a member? Log in here
  Share:

Author: Michael Patrini

…

Membership Required

You must be a member to access this content.

View Membership Levels

Already a member? Log in here